Institute of Microbiology, Swiss Federal Institute of Technology (ETH) Zürich, 8093 Zürich, Switzerland.
Institute for Experimental Infection Research, TWINCORE, Centre for Experimental and Clinical Infection Research, a joint venture between the Hannover Medical School and the Helmholtz Centre for Infection Research, 30625 Hannover, Germany.
Nat Rev Immunol. 2015 Apr;15(4):231-42. doi: 10.1038/nri3806. Epub 2015 Mar 20.
Type I interferons (IFNs) are pro-inflammatory cytokines that are rapidly induced in different cell types during viral infections. The consequences of type I IFN signalling include direct antiviral activity, innate immune cell activation and regulation of adaptive immune responses. In this Review, we discuss recent conceptual advances in our understanding of indirect and direct regulation of T cell immunity by type I IFNs, which can either promote or inhibit T cell activation, proliferation, differentiation and survival. This regulation depends, to a large extent, on the timing of type I IFN exposure relative to T cell receptor signalling. Type I IFNs also provide activated T cells with resistance to natural killer cell-mediated elimination.
I 型干扰素(IFN)是促炎细胞因子,在病毒感染期间可迅速在不同细胞类型中诱导产生。I 型 IFN 信号转导的后果包括直接抗病毒活性、先天免疫细胞激活和适应性免疫反应的调节。在这篇综述中,我们讨论了对 I 型 IFN 间接和直接调节 T 细胞免疫的理解的最新概念进展,这些进展可以促进或抑制 T 细胞的激活、增殖、分化和存活。这种调节在很大程度上取决于 I 型 IFN 暴露相对于 T 细胞受体信号转导的时间。I 型干扰素还为激活的 T 细胞提供了对自然杀伤细胞介导的消除的抗性。
Nat Rev Immunol. 2015-3-20
J Interferon Cytokine Res. 2004-8
Semin Immunol. 2019-6
Semin Immunol. 2019-5-30
Curr Opin Virol. 2016-2
Curr Opin Immunol. 2015-6
Immunity. 2006-9
Immunol Lett. 2019-2-13
Immunol Cell Biol. 2012-3-6
Proc Natl Acad Sci U S A. 2025-8-19
Cell Mol Immunol. 2025-7-9
Life Sci Alliance. 2025-4-2
Trends Immunol. 2015-1
Nat Rev Immunol. 2014-7-18
Proc Natl Acad Sci U S A. 2014-6-2
Proc Natl Acad Sci U S A. 2014-5-5